Completed
Genotype-Directed Dose-Escalation Study of Irinotecan in Patients With Advanced Solid Tumors
NCT00708773
- Conditions
- Advanced Cancer
- Locations
-
- University of Chicago Chicago, Illinois, United States
- NorthShore University HealthSystem Evanston, Illinois, United States